Literature DB >> 23125241

Do educated natural killer cells make the grade in treating acute myeloid leukemia?

Ronjon Chakraverty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23125241      PMCID： PMC3487430          DOI： 10.3324/haematol.2012.078717

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

Review 1.  Overview of the killer cell immunoglobulin-like receptor system.

Authors:  Raja Rajalingam
Journal:  Methods Mol Biol       Date:  2012

2.  Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.

Authors:  Cyril Fauriat; Martin A Ivarsson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg; Jakob Michaëlsson
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

3.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Authors:  Jeffrey M Venstrom; Gianfranco Pittari; Ted A Gooley; Joseph H Chewning; Stephen Spellman; Michael Haagenson; Meighan M Gallagher; Mari Malkki; Effie Petersdorf; Bo Dupont; Katharine C Hsu
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

4.  Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Daniel J Weisdorf; Lisbeth A Guethlein; John P Klein; Tao Wang; Chap T Le; Steven G E Marsh; Daniel Geraghty; Stephen Spellman; Michael D Haagenson; Martha Ladner; Elizabeth Trachtenberg; Peter Parham; Jeffrey S Miller
Journal:  Blood       Date:  2010-06-25       Impact factor: 22.113

Review 5.  Biology and clinical effects of natural killer cells in allogeneic transplantation.

Authors:  Jonathan E Benjamin; Saar Gill; Robert S Negrin
Journal:  Curr Opin Oncol       Date:  2010-03       Impact factor: 3.645

6.  Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Elizabeth Trachtenberg; Tracy L Bergemann; Koy Saeteurn; John Klein; Chap T Le; Steven G E Marsh; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.